查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1266327

连续血糖监测系统市场：按组件、人口统计和最终用户分类：2021-2031 年全球机会分析和行业预测

Continuous Glucose Monitoring Systems Market By Component, By Demography, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 284 Pages | 商品交期: 2-3个工作天内

价格

连续血糖监测系统市场价值在 2021 年为 66.266 亿美元，到 2031 年将达到 317.082 亿美元，从 2022 年到 2031 年预计将以 17.0% 的复合年增长率增长。

连续血糖监测系统 (CGM) 市场已成为一种很有前途的糖尿病管理工具，用于监测所有类型的糖尿病患者。 CGM 主要用于低血糖和高血糖患者。 市场上有几种不同类型的 CGM 系统，包括间质液 CGM、血糖 CGM 和混合闭环 CGM，每种都具有独特的功能和优势。 这些系统具有多种优势，包括改善血糖控制、减少指尖刺血测试的需要、更好地识别血糖模式以及提高生活质量。

连续血糖监测系统市场的增长受到以下因素的推动：糖尿病患者人数的增加、技术进步（例如能够实时测量血糖的小型化和可穿戴设备的市场开放）以及患者对益处的认识不断提高CGM.. 糖尿病患病率的增加正在推动人们广泛采用 CGM 来监测血糖水平。 CGM 使用植入皮肤的传感器测量间质液中的葡萄糖水平，并使用接收器显示读数。 例如，根据国际糖尿病联合会 (IDF) 的数据，到 2021 年全球将有大约 5.37 亿成年人患有糖尿病。 根据同一数据，超过四分之三的成人糖尿病患者生活在印度和中国等低收入和中等收入国家。 因此，糖尿病患病率的上升导致对 CGM 的需求增加，这反过来又促进了市场增长。

此外，越来越多的政府举措和报销政策是推动市场增长的主要因素。 例如，澳大利亚政府实施了一项持续血糖监测 (CGM) 计划，作为国家糖尿病服务计划 (NDSS) 的一部分，该计划为符合条件的 1 型糖尿病患者提供获得全额补贴的 Dexcom CGM 的机会。 该倡议旨在改善 1 型糖尿病患者的生活质量并降低糖尿病相关并发症的风险。 通过提供完全补贴的 CGM，政府正在帮助 1 型糖尿病患者更广泛地使用和使用这些设备。 此外，增加 CGM 临床评估的资金活动也有助于市场增长。 例如，欧盟委员会的Horizo□□n 2020计划已提供285万美元继续开发无创触摸血糖监测技术GlucoBeam。 因此，政府的此类举措有助于公司继续研究和测试新的 CGM，从而促进市场的增长。

然而，CGM 系统的高成本和设备复杂性限制了 CGM 的采用，从而限制了市场的增长。

另一方面，美国、加拿大等发达国家和世界其他地区对医疗器械的需求正在增加，而新兴市场有望提供增长机会，为 CGM 带来巨大的业务在预测期间。机会很可能会出现。

连续血糖监测系统市场根据组件、人口统计、最终用户和地区进行细分。 基于组件，市场分为传感器和发射器和接收器。 根据人口统计数据，市场分为儿科人群（□14 岁）和成人人群（>14 岁）。 按最终用户划分，市场分为医院和诊所、家庭保健等。 其他包括门诊设置和诊断中心。

内容

第 1 章介绍

第 2 章执行摘要

第 3 章市场概述

  • 市场定义和范围
  • 主要发现
    • 主要影响因素
    • 主要投资机会
  • 波特五力分析
    • 供应商的议价能力
    • 买家的议价能力
    • 替代品的威胁
    • 新进入者的威胁
    • 竞争激烈程度
  • 市场动态
    • 促进因素
      • 患糖尿病的人数增加
      • CGM 相对于传统血糖监测设备的优势
      • CGM 在家庭保健和 ICU 中的采用率很高
    • 抑制因素
      • 与 CGM 相关的副作用
      • CGM 的成本很高
    • 机会
      • 未确诊患者人数众多
      • CGM技术进展
  • 分析 COVID-19 对市场的影响

第 4 章连续血糖监测系统市场：按组件分类

  • 概览
    • 市场规模和预测
  • 传感器
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 发送器和接收器
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类

第 5 章连续血糖监测系统市场：按人口统计

  • 概览
    • 市场规模和预测
  • 儿童人口
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 成年人口
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类

第 6 章连续血糖监测系统市场：按最终用户分类

  • 概览
    • 市场规模和预测
  • 医院和诊所
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 家庭保健
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 其他
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类

第 7 章连续血糖监测系统市场：按地区

  • 概览
    • 市场规模和预测：按地区
  • 北美
    • 主要趋势和机会
    • 各组成部分的市场规模和预测
    • 市场规模和预测：按人口统计
    • 最终用户的市场规模和预测
    • 市场规模和预测：按国家/地区分类
      • 美国
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
      • 加拿大
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
      • 墨西哥
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
  • 欧洲
    • 主要趋势和机会
    • 各组成部分的市场规模和预测
    • 市场规模和预测：按人口统计
    • 最终用户的市场规模和预测
    • 市场规模和预测：按国家/地区分类
      • 德国
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
      • 法国
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
      • 英国
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
      • 意大利
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
      • 俄罗斯
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
      • 西班牙
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
      • 荷兰
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
      • 挪威
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
      • 瑞典
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
      • 丹麦
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
      • 芬兰
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
      • 其他欧洲
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
  • 亚太地区
    • 主要趋势和机会
    • 各组成部分的市场规模和预测
    • 市场规模和预测：按人口统计
    • 最终用户的市场规模和预测
    • 市场规模和预测：按国家/地区分类
      • 日本
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
      • 中国
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
      • 印度
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
      • 澳大利亚
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
      • 韩国
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
      • 新西兰
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
      • 菲律宾
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
      • 其他亚太地区
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
  • 拉丁美洲/中东/非洲
    • 主要趋势和机会
    • 各组成部分的市场规模和预测
    • 市场规模和预测：按人口统计
    • 最终用户的市场规模和预测
    • 市场规模和预测：按国家/地区分类
      • 巴西
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
      • 沙特阿拉伯
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
      • 南非
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
      • 委内瑞拉
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
      • 阿根廷
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测
      • 其他拉美地区
      • 主要市场趋势、增长动力和机遇
      • 各组成部分的市场规模和预测
      • 市场规模和预测：按人口统计
      • 最终用户的市场规模和预测

第 8 章竞争格局

  • 介绍
  • 关键成功策略
  • 排名前 10 位的玩家产品映射
  • 竞争仪表板
  • 竞争热图
  • 2021 年最佳球员排名

第 9 章公司简介

  • Medtronic plc
  • Abbott Laboratories
  • DexCom, Inc.
  • Senseonics
  • Johnson & Johnson
  • A. Menarini Diagnostics S.r.l
  • Novo Nordisk A/S
  • GlySens Incorporated
  • Ypsomed AG
  • F. Hoffman-La Roche Ltd
Product Code: A01466

The continuous glucose monitoring systems market was valued at $6,626.6 million in 2021, and is estimated to reach $31,708.2 million by 2031, growing at a CAGR of 17.0% from 2022 to 2031.The continuous glucose monitoring systems (CGMs) market has emerged as a promising diabetes management tool for monitoring all types of diabetic patients. CGMs are mainly used by patients suffering from hypo and hyperglycemic conditions. There are several different types of CGM systems available in the market, each with its own set of features and benefits such as interstitial fluid CGMs, blood glucose CGMs, and hybrid closed loop CGMs. These systems offer various advantages such as improved glucose control, reduced need for fingerstick testing, increased awareness of glucose patterns, and improved quality of life.

The continuous glucose monitoring systems market growth is driven by increase in number of patients suffering from diabetes; rise in technological advancements such as the development of miniaturized and wearable devices that can provide real-time glucose readings; and increase in patient awareness about be benefits of CGMs. The rise in prevalence of diabetes propels high adoption of CGMs for monitoring glucose levels. The sensor is implanted in the layer of skin which measure glucose levels in the interstitial fluid and a receiver displays the readings. For instance, according to International Diabetes Federation (IDF), about 537 million adults are living with diabetes in 2021, across the globe. In addition, as per the same source, over 3 in 4 adults with diabetes live in low and middle-income countries such as India and China. Thus, rise in the prevalence of diabetes has resulted in increased demand for CGMs, which, in turn, contribute to the market growth.

Furthermore, increase in government initiatives and reimbursement policies are the key factors that boost the market growth. For instance, the Australian Government has implemented the continuous glucose monitoring (CGM) Initiative as part of the National Diabetes Services Scheme (NDSS) to provide access to fully subsidized Dexcom CGMs for eligible people with Type 1 diabetes. This initiative is designed to improve the quality of life for people with Type 1 diabetes and reduce the risk of complications associated with the condition. By providing access to fully subsidized CGMs, the government is helping to make these devices more widely available and accessible to people with Type 1 diabetes. Furthermore, rise in funding activities to conduct the clinical evaluations of CGMs, further contribute towards the market growth. For instance, European Commission's Horizon 2020 program provided funding of $2.85 million for the continued development of non-invasive touch glucose monitoring technology, GlucoBeam. Therefore, such initiatives taken by government supports the company to continue the research and testing of novel CGMs, which, in turn, boost the market growth.

However, the high cost of CGM systems, and complexity of devices limit the adoption of CGMs, which, in turn, restrains the market growth.

On the other hand, increased demand of medical devices in the developed countries such as the U.S., Canada, and rest of world and growth potential in emerging markets expected to create immense opportunities for CGMs during the forecast period.

The continuous glucose monitoring systems market is segmented on the basis of component, demography, end user, and region. On the basis of component, the market is classified into sensors and transmitters & receivers. On the basis of demography, the market is segmented into child population (≤14 years) and adult population (>14 years). On the basis of end user, the market is classified into hospitals & clinics, home healthcare, and others. The others include ambulatory settings and diagnostic center.

Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Spain, Italy, Netherlands, Norway, Sweden, Denmark, Finland, and rest of Europe), Asia-Pacific (India, China, Australia, Japan, South Korea, New Zealand, Philippines, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, Venezuela, Argentina, and rest of LAMEA).

Major key players that operate in the global continuous glucose monitoring systems market are: A. Menarini, Diagnostics S.r.l, Abbott Laboratories, DexCom, Inc., F. Hoffman-La Roche Ltd, GlySens Incorporated, Johnson & Johnson, Medtronic plc, Novo Nordisk A/S, Senseonics, and Ypsomed AG.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the continuous glucose monitoring systems market analysis from 2021 to 2031 to identify the prevailing continuous glucose monitoring systems market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the continuous glucose monitoring systems market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global continuous glucose monitoring systems market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Demography

  • Child Population
  • Adult Population

By End User

  • Home healthcare
  • Others
  • Hospital and Clinics

By Component

  • Transmitters and Receivers 
  • Sensors 

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Spain
    • Netherlands
    • Norway
    • Sweden
    • Denmark
    • Finland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • New Zealand
    • Philippines
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Venezuela 
    • Argentina 
    • Rest of LAMEA

Key Market Players

  • Medtronic plc
  • DexCom, Inc.
  • Johnson & Johnson
  • F. Hoffman-La Roche Ltd
  • GlySens Incorporated
  • Novo Nordisk A/S
  • Abbott Laboratories
  • Senseonics
  • A. Menarini Diagnostics S.r.l
  • Ypsomed AG

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Bargaining power of suppliers
    • 3.3.2. Bargaining power of buyers
    • 3.3.3. Threat of substitutes
    • 3.3.4. Threat of new entrants
    • 3.3.5. Intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in number of people suffering from diabetes
      • 3.4.1.2. Benefits of CGMs over conventional glucose monitoring devices
      • 3.4.1.3. High adoption rate of CGMs in home healthcare and ICUs
    • 3.4.2. Restraints
      • 3.4.2.1. Adverse effects associated with CGMs
      • 3.4.2.2. High cost of CGMs
    • 3.4.3. Opportunities
      • 3.4.3.1. High undiagnosed patient population
      • 3.4.3.2. Technological advancement in CGMs
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Sensors 
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Transmitters and Receivers 
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Child Population
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Adult Population
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country

CHAPTER 6: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospital and Clinics
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Home healthcare
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key trends and opportunities
    • 7.2.2. Market size and forecast, by Component
    • 7.2.3. Market size and forecast, by Demography
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Key market trends, growth factors and opportunities
      • 7.2.5.1.2. Market size and forecast, by Component
      • 7.2.5.1.3. Market size and forecast, by Demography
      • 7.2.5.1.4. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Key market trends, growth factors and opportunities
      • 7.2.5.2.2. Market size and forecast, by Component
      • 7.2.5.2.3. Market size and forecast, by Demography
      • 7.2.5.2.4. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Key market trends, growth factors and opportunities
      • 7.2.5.3.2. Market size and forecast, by Component
      • 7.2.5.3.3. Market size and forecast, by Demography
      • 7.2.5.3.4. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key trends and opportunities
    • 7.3.2. Market size and forecast, by Component
    • 7.3.3. Market size and forecast, by Demography
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Key market trends, growth factors and opportunities
      • 7.3.5.1.2. Market size and forecast, by Component
      • 7.3.5.1.3. Market size and forecast, by Demography
      • 7.3.5.1.4. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Key market trends, growth factors and opportunities
      • 7.3.5.2.2. Market size and forecast, by Component
      • 7.3.5.2.3. Market size and forecast, by Demography
      • 7.3.5.2.4. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Key market trends, growth factors and opportunities
      • 7.3.5.3.2. Market size and forecast, by Component
      • 7.3.5.3.3. Market size and forecast, by Demography
      • 7.3.5.3.4. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Key market trends, growth factors and opportunities
      • 7.3.5.4.2. Market size and forecast, by Component
      • 7.3.5.4.3. Market size and forecast, by Demography
      • 7.3.5.4.4. Market size and forecast, by End User
      • 7.3.5.5. Russia
      • 7.3.5.5.1. Key market trends, growth factors and opportunities
      • 7.3.5.5.2. Market size and forecast, by Component
      • 7.3.5.5.3. Market size and forecast, by Demography
      • 7.3.5.5.4. Market size and forecast, by End User
      • 7.3.5.6. Spain
      • 7.3.5.6.1. Key market trends, growth factors and opportunities
      • 7.3.5.6.2. Market size and forecast, by Component
      • 7.3.5.6.3. Market size and forecast, by Demography
      • 7.3.5.6.4. Market size and forecast, by End User
      • 7.3.5.7. Netherlands
      • 7.3.5.7.1. Key market trends, growth factors and opportunities
      • 7.3.5.7.2. Market size and forecast, by Component
      • 7.3.5.7.3. Market size and forecast, by Demography
      • 7.3.5.7.4. Market size and forecast, by End User
      • 7.3.5.8. Norway
      • 7.3.5.8.1. Key market trends, growth factors and opportunities
      • 7.3.5.8.2. Market size and forecast, by Component
      • 7.3.5.8.3. Market size and forecast, by Demography
      • 7.3.5.8.4. Market size and forecast, by End User
      • 7.3.5.9. Sweden
      • 7.3.5.9.1. Key market trends, growth factors and opportunities
      • 7.3.5.9.2. Market size and forecast, by Component
      • 7.3.5.9.3. Market size and forecast, by Demography
      • 7.3.5.9.4. Market size and forecast, by End User
      • 7.3.5.10. Denmark
      • 7.3.5.10.1. Key market trends, growth factors and opportunities
      • 7.3.5.10.2. Market size and forecast, by Component
      • 7.3.5.10.3. Market size and forecast, by Demography
      • 7.3.5.10.4. Market size and forecast, by End User
      • 7.3.5.11. Finland
      • 7.3.5.11.1. Key market trends, growth factors and opportunities
      • 7.3.5.11.2. Market size and forecast, by Component
      • 7.3.5.11.3. Market size and forecast, by Demography
      • 7.3.5.11.4. Market size and forecast, by End User
      • 7.3.5.12. Rest of Europe
      • 7.3.5.12.1. Key market trends, growth factors and opportunities
      • 7.3.5.12.2. Market size and forecast, by Component
      • 7.3.5.12.3. Market size and forecast, by Demography
      • 7.3.5.12.4. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key trends and opportunities
    • 7.4.2. Market size and forecast, by Component
    • 7.4.3. Market size and forecast, by Demography
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Key market trends, growth factors and opportunities
      • 7.4.5.1.2. Market size and forecast, by Component
      • 7.4.5.1.3. Market size and forecast, by Demography
      • 7.4.5.1.4. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Key market trends, growth factors and opportunities
      • 7.4.5.2.2. Market size and forecast, by Component
      • 7.4.5.2.3. Market size and forecast, by Demography
      • 7.4.5.2.4. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Key market trends, growth factors and opportunities
      • 7.4.5.3.2. Market size and forecast, by Component
      • 7.4.5.3.3. Market size and forecast, by Demography
      • 7.4.5.3.4. Market size and forecast, by End User
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Key market trends, growth factors and opportunities
      • 7.4.5.4.2. Market size and forecast, by Component
      • 7.4.5.4.3. Market size and forecast, by Demography
      • 7.4.5.4.4. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Key market trends, growth factors and opportunities
      • 7.4.5.5.2. Market size and forecast, by Component
      • 7.4.5.5.3. Market size and forecast, by Demography
      • 7.4.5.5.4. Market size and forecast, by End User
      • 7.4.5.6. New Zealand
      • 7.4.5.6.1. Key market trends, growth factors and opportunities
      • 7.4.5.6.2. Market size and forecast, by Component
      • 7.4.5.6.3. Market size and forecast, by Demography
      • 7.4.5.6.4. Market size and forecast, by End User
      • 7.4.5.7. Philippines
      • 7.4.5.7.1. Key market trends, growth factors and opportunities
      • 7.4.5.7.2. Market size and forecast, by Component
      • 7.4.5.7.3. Market size and forecast, by Demography
      • 7.4.5.7.4. Market size and forecast, by End User
      • 7.4.5.8. Rest of Asia-Pacific
      • 7.4.5.8.1. Key market trends, growth factors and opportunities
      • 7.4.5.8.2. Market size and forecast, by Component
      • 7.4.5.8.3. Market size and forecast, by Demography
      • 7.4.5.8.4. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key trends and opportunities
    • 7.5.2. Market size and forecast, by Component
    • 7.5.3. Market size and forecast, by Demography
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Key market trends, growth factors and opportunities
      • 7.5.5.1.2. Market size and forecast, by Component
      • 7.5.5.1.3. Market size and forecast, by Demography
      • 7.5.5.1.4. Market size and forecast, by End User
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Key market trends, growth factors and opportunities
      • 7.5.5.2.2. Market size and forecast, by Component
      • 7.5.5.2.3. Market size and forecast, by Demography
      • 7.5.5.2.4. Market size and forecast, by End User
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Key market trends, growth factors and opportunities
      • 7.5.5.3.2. Market size and forecast, by Component
      • 7.5.5.3.3. Market size and forecast, by Demography
      • 7.5.5.3.4. Market size and forecast, by End User
      • 7.5.5.4. Venezuela 
      • 7.5.5.4.1. Key market trends, growth factors and opportunities
      • 7.5.5.4.2. Market size and forecast, by Component
      • 7.5.5.4.3. Market size and forecast, by Demography
      • 7.5.5.4.4. Market size and forecast, by End User
      • 7.5.5.5. Argentina 
      • 7.5.5.5.1. Key market trends, growth factors and opportunities
      • 7.5.5.5.2. Market size and forecast, by Component
      • 7.5.5.5.3. Market size and forecast, by Demography
      • 7.5.5.5.4. Market size and forecast, by End User
      • 7.5.5.6. Rest of LAMEA
      • 7.5.5.6.1. Key market trends, growth factors and opportunities
      • 7.5.5.6.2. Market size and forecast, by Component
      • 7.5.5.6.3. Market size and forecast, by Demography
      • 7.5.5.6.4. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

  • 9.1. Medtronic plc
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
    • 9.1.7. Key strategic moves and developments
  • 9.2. Abbott Laboratories
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
    • 9.2.7. Key strategic moves and developments
  • 9.3. DexCom, Inc.
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
    • 9.3.7. Key strategic moves and developments
  • 9.4. Senseonics
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Key strategic moves and developments
  • 9.5. Johnson & Johnson
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
  • 9.6. A. Menarini Diagnostics S.r.l
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
  • 9.7. Novo Nordisk A/S
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
  • 9.8. GlySens Incorporated
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
  • 9.9. Ypsomed AG
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Business performance
  • 9.10. F. Hoffman-La Roche Ltd
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance

LIST OF TABLES

  • TABLE 01. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 02. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR SENSORS , BY REGION, 2021-2031 ($MILLION)
  • TABLE 03. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TRANSMITTERS AND RECEIVERS , BY REGION, 2021-2031 ($MILLION)
  • TABLE 04. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 05. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR CHILD POPULATION, BY REGION, 2021-2031 ($MILLION)
  • TABLE 06. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR ADULT POPULATION, BY REGION, 2021-2031 ($MILLION)
  • TABLE 07. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 08. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOSPITAL AND CLINICS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 09. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOME HEALTHCARE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 11. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 12. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 13. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 14. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 15. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 16. U.S. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 17. U.S. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 18. U.S. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 19. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 20. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 21. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 22. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 23. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 24. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 25. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 26. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 27. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 28. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 29. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 30. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 31. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 32. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 33. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 34. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 35. UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 36. UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 37. UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 38. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 39. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 40. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 41. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 42. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 43. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 44. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 45. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 46. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 47. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 48. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 49. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 50. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 51. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 52. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 53. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 54. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 55. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 56. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 57. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 58. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 59. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 60. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 61. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 62. REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 63. REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 64. REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 65. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 66. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 67. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 68. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 69. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 70. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 71. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 72. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 73. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 74. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 75. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 76. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 77. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 78. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 79. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 80. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 81. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 82. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 83. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 84. NEW ZEALAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 85. NEW ZEALAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 86. NEW ZEALAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 87. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 88. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 89. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 90. REST OF ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 91. REST OF ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 92. REST OF ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 93. LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 94. LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 95. LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 96. LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 97. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 98. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 99. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 100. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 101. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 102. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 103. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 104. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 105. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 106. VENEZUELA  CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 107. VENEZUELA  CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 108. VENEZUELA  CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 109. ARGENTINA  CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 110. ARGENTINA  CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 111. ARGENTINA  CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 112. REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 113. REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 114. REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 115. MEDTRONIC PLC: KEY EXECUTIVES
  • TABLE 116. MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 117. MEDTRONIC PLC: PRODUCT SEGMENTS
  • TABLE 118. MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 119. MEDTRONIC PLC: KEY STRATERGIES
  • TABLE 120. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 121. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 122. ABBOTT LABORATORIES: PRODUCT SEGMENTS
  • TABLE 123. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 124. ABBOTT LABORATORIES: KEY STRATERGIES
  • TABLE 125. DEXCOM, INC.: KEY EXECUTIVES
  • TABLE 126. DEXCOM, INC.: COMPANY SNAPSHOT
  • TABLE 127. DEXCOM, INC.: PRODUCT SEGMENTS
  • TABLE 128. DEXCOM, INC.: PRODUCT PORTFOLIO
  • TABLE 129. DEXCOM, INC.: KEY STRATERGIES
  • TABLE 130. SENSEONICS: KEY EXECUTIVES
  • TABLE 131. SENSEONICS: COMPANY SNAPSHOT
  • TABLE 132. SENSEONICS: PRODUCT SEGMENTS
  • TABLE 133. SENSEONICS: PRODUCT PORTFOLIO
  • TABLE 134. SENSEONICS: KEY STRATERGIES
  • TABLE 135. JOHNSON & JOHNSON: KEY EXECUTIVES
  • TABLE 136. JOHNSON & JOHNSON: COMPANY SNAPSHOT
  • TABLE 137. JOHNSON & JOHNSON: PRODUCT SEGMENTS
  • TABLE 138. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
  • TABLE 139. A. MENARINI DIAGNOSTICS S.R.L: KEY EXECUTIVES
  • TABLE 140. A. MENARINI DIAGNOSTICS S.R.L: COMPANY SNAPSHOT
  • TABLE 141. A. MENARINI DIAGNOSTICS S.R.L: PRODUCT SEGMENTS
  • TABLE 142. A. MENARINI DIAGNOSTICS S.R.L: PRODUCT PORTFOLIO
  • TABLE 143. NOVO NORDISK A/S: KEY EXECUTIVES
  • TABLE 144. NOVO NORDISK A/S: COMPANY SNAPSHOT
  • TABLE 145. NOVO NORDISK A/S: PRODUCT SEGMENTS
  • TABLE 146. NOVO NORDISK A/S: PRODUCT PORTFOLIO
  • TABLE 147. GLYSENS INCORPORATED: KEY EXECUTIVES
  • TABLE 148. GLYSENS INCORPORATED: COMPANY SNAPSHOT
  • TABLE 149. GLYSENS INCORPORATED: PRODUCT SEGMENTS
  • TABLE 150. GLYSENS INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 151. YPSOMED AG: KEY EXECUTIVES
  • TABLE 152. YPSOMED AG: COMPANY SNAPSHOT
  • TABLE 153. YPSOMED AG: PRODUCT SEGMENTS
  • TABLE 154. YPSOMED AG: PRODUCT PORTFOLIO
  • TABLE 155. F. HOFFMAN-LA ROCHE LTD: KEY EXECUTIVES
  • TABLE 156. F. HOFFMAN-LA ROCHE LTD: COMPANY SNAPSHOT
  • TABLE 157. F. HOFFMAN-LA ROCHE LTD: PRODUCT SEGMENTS
  • TABLE 158. F. HOFFMAN-LA ROCHE LTD: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET (2022-2031)
  • FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. LOW BARGAINING POWER OF BUYERS
  • FIGURE 06. LOW THREAT OF SUBSTITUTES
  • FIGURE 07. LOW THREAT OF NEW ENTRANTS
  • FIGURE 08. LOW INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALCONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
  • FIGURE 10. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR SENSORS , BY COUNTRY 2021-2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TRANSMITTERS AND RECEIVERS , BY COUNTRY 2021-2031(%)
  • FIGURE 13. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR CHILD POPULATION, BY COUNTRY 2021-2031(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR ADULT POPULATION, BY COUNTRY 2021-2031(%)
  • FIGURE 16. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOSPITAL AND CLINICS, BY COUNTRY 2021-2031(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOME HEALTHCARE, BY COUNTRY 2021-2031(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 20. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY REGION, 2021
  • FIGURE 21. U.S. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 22. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 23. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 24. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 25. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 26. UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 27. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 28. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 29. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 30. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 31. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 40. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 41. NEW ZEALAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 42. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 43. REST OF ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 44. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 45. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 46. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 47. VENEZUELA  CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 48. ARGENTINA  CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 49. REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 50. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 51. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 52. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 53. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 54. COMPETITIVE DASHBOARD
  • FIGURE 55. COMPETITIVE HEATMAP: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
  • FIGURE 56. TOP PLAYER POSITIONING, 2021
  • FIGURE 57. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 59. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 60. ABBOTT LABORATORIES: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 61. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 62. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 63. DEXCOM, INC.: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 64. DEXCOM, INC.: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 65. JOHNSON & JOHNSON: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 66. JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 67. JOHNSON & JOHNSON: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 68. NOVO NORDISK A/S: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 69. NOVO NORDISK A/S: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 70. NOVO NORDISK A/S: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 71. YPSOMED AG: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 72. YPSOMED AG: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 73. YPSOMED AG: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 74. F. HOFFMANN-LA ROCHE LTD.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 75. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 76. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY REGION, 2022 (%)